Prosthodontic rehabilitation of a mucormycosis patient: a case report
Article Sidebar
Main Article Content
Abstract
Maxillofacial defects can result from congenital disabilities, cancer surgery, trauma, infection, or disease. Facial deformities can affect how a person looks, feels about themselves, and interacts with others. It can significantly impair phonetics, mastication, and deglutition and cause facial deformation. Maxillectomy due to mucormycosis is one such maxillofacial defect and it becomes essential to rehabilitate these cases with modified techniques based on the extension of intraoral defect, the severity, the degree of resection, the type of mucormycosis, the stability of lesions over time, the presence of contiguous disease, the accessibility of dental and prosthetic resources, and patient expectations. The prosthetic reconstruction with a maxillofacial prosthesis can restore function and appearance, comfort, and quality of life. The prosthesis should be simple to handle, easy to maintain, biocompatible, light in weight, and convenient for future adjustments. The maxillofacial surgeon, oncologist, and reconstructive dentist should work together to develop a treatment plan based on these considerations. This case report provides the current treatment options for these patients and rehabilitation of the defect. It also discusses the issues that need to be addressed during the planning of prosthetic treatment and highlights some challenges the clinicians face in providing prosthetic treatment for mucormycosis patients.
Article Details
Section
This work is licensed under a Creative Commons Attribution 4.0 International License.
This work is licensed under a Creative Commons Attribution 4.0 International License.
How to Cite
References
Rani G, Gambhir A. Prosthodontic Rehabilitation of a Patient with Subtotal Maxillectomy using a Hollow Bulb Obturator. Int J Prosthodont Restor Dent 2012; 2(1):24-28. https://doi.org/10.5005/jp-journals-10019-1042
Cornely OA, Alastruey-Izquierdo A, Arenz D, et al. Global guideline for the diagnosis and management of mucormycosis: an initiative of the European confederation of medical mycology in cooperation with the Mycoses Study Group education and research consortium. Lancet Infect Dis. 2019;19(12): e405–e421.
Gupta AD, Verma A, Islam JI, Agarwal S. Maxillofacial defects and their classification: a review. IJAR. 2016;4(6):109–14. https://doi.org/10.21474/IJAR01/618
Wang RR. Sectional prosthesis for total maxillectomy patients: a clinical report. J Prosthet Dent. 1997 Sep 1;78(3):241-4. https://doi.org/10.1016/S0022-3913(97)70020-9
Keyf F. Obturator prostheses for hemimaxillectomy patients. J Oral Rehabil. 2001 Sep;28(9):821-9. https://doi.org/10.1046/j.1365-2842.2001.00754.x
Francis L. Rehabilitation of a patient with facial and palatal defect - a case report. J Clin Diagn Res. 2017;11(3): ZD19-20. https://doi.org/10.7860/JCDR/2017/25063.9540
Ahmadikia K, Hashemi SJ, Khodavaisy S, et al. The double-edged sword of systemic corticosteroid therapy in viral pneumonia: a case report and comparative review of influenza-associated mucormycosis versus COVID-19-associated mucormycosis. Mycoses. 2021;64 (8):798–808. https://doi.org/10.1111/myc.13256
Vero N, Mishra N, Singh BP, Singh K, Jurel SK, Kumar V. Assessment of swallowing and masticatory performance in obturator wearers: a clinical study. J Adv Prosthodont. 2015;7(1):8–14. https://doi.org/10.4047/jap.2015.7.1.8
Cervino G, Fiorillo L, Herford AS, et al. Alginate materials and dental impression technique: a current state of the art and application to dental practice. Mar Drugs. 2018;17(1):18. https://doi.org/10.3390/md17010018